Back to today’s briefing

Story perspectives

Novo Nordisk Foundation Proposes Board Overhaul for U.S. Focus

10/21/2025

32 5

Summary

Story summary

The Novo Nordisk Foundation, Novo Nordisk's largest investor, plans a board overhaul and has proposed Lars Rebien Sørensen as the new chair to accelerate decision-making and focus on the U.S. market.
The move follows concerns that Novo Nordisk responds too slowly to market changes, especially in the United States.
Helge Lund, current chair of Novo Nordisk's board, and six independent directors will step down at a meeting on November 14.

1 of 1

Story summary

The Novo Nordisk Foundation, Novo Nordisk's largest investor, plans a board overhaul and has proposed Lars Rebien Sørensen as the new chair to accelerate decision-making and focus on the U.S. market.
The move follows concerns that Novo Nordisk responds too slowly to market changes, especially in the United States.
Helge Lund, current chair of Novo Nordisk's board, and six independent directors will step down at a meeting on November 14.